Skip to main content

Isomorphic signs drug discovery deals with Eli Lilly and Novartis

The company aims to use the power of AI to tackle various diseases and could receive nearly $3bn from its new research collaborations.


Read more: Isomorphic signs drug discovery deals with Eli Lilly and Novartis


https://bit.ly/48MGUEb